Count and document activity, assess infection and systemic associations, then match anti-inflammatory and cause-directed treatment.
Terminology and draft status
Terminology review is not complete. Selected actual WHO UMD queries and their limits are recorded in terminology.md; they do not approve the whole translation.
01Describe activity and course first
Anterior uveitis has its primary inflammation in the anterior chamber; minor anterior vitreous spillover does not change that classification. Cells support active anterior inflammation. Flare reflects blood–aqueous barrier disturbance and can persist after cell activity subsides; it is not simply proof of an old episode or, alone, a universal activity measure. 1 2
SUN anterior cells are grade 0 below 1 cell, 0.5+ at 1–5, 1+ at 6–15, 2+ at 16–25, 3+ at 26–50 and 4+ above 50 cells in that field. Hypopyon is recorded separately, not automatically converted to cell grade 4+. Fibrin can obscure assessment and belongs in its own description; severe flare with fibrin is not the same scale as cell count. Vitreous haze is graded by disc and vessel visibility, separately from anterior cells. 2
Describe onset as sudden or insidious and duration as limited (up to 3 months) or persistent (more than 3 months). Acute means sudden onset with limited duration; recurrent episodes are separated by at least 3 months of inactivity without treatment. Chronic disease is persistent and relapses promptly, within 3 months after treatment stops. Duration alone is not the entire course classification. 2
Granulomatous morphology includes large mutton-fat KPs and iris nodules; fine KPs suggest non-granulomatous disease, without proving an aetiology. Immune-mediated, infectious and unexplained disease overlap clinically. The original infectious up-to20% and idiopathic up-to40% estimates lack a defined population here and must not be taught as universal prevalence. 1
| Grade | Cells in 1×1 mm field |
|---|---|
| 0 | <1 |
| 0.5+ | 1–5 |
| 1+ | 6–15 |
| 2+ | 16–25 |
| 3+ | 26–50 |
| 4+ | >50 |
02Read the cornea, iris and pressure together
Pain, photophobia, ciliary redness and blur are common but not obligatory; JIA children may have asymptomatic white eyes. Ciliary injection is a clue rather than a reliable separation from every conjunctivitis or keratitis. Examine before dilation where feasible and assess the posterior segment as well. 1
Document fine, mutton-fat, pigmented or stellate KPs; old pigment deposits may persist, and a Krukenberg spindle is pigment rather than proof of uveitis. Band keratopathy reflects chronic inflammation or calcium disorders. Record cells/flare, hypopyon, hyphema, Koeppe nodules at the pupil, Busacca nodules on the stroma, posterior synechiae and diffuse/sectoral iris atrophy. None of these signs alone is pathognomonic. 1
Granulomatous disease raises sarcoid, TB and herpes questions. Hypopyon can accompany HLA-B27 or Behçet, but infection and malignancy remain alternatives; an irregular blood-stained pseudohypopyon can suggest leukaemia. The original Behçet10% estimate is population-dependent and unverified here. Hyphema or keratouveitis can suggest herpes, while sclerouveitis requires attention to infection and systemic vasculitis such as GPA (formerly Wegener) or PAN. 1
03Distinguish recurrent acute patterns
HLA-B27-associated spondyloarthritis often causes acute, recurrent, unilateral non-granulomatous disease that may alternate eyes. Fibrin, synechiae, hypopyon and CME may occur. The original example of 0.5+ rising to3–4+ over 1–2 days illustrates possible rapid escalation, not a mandatory prodrome or a reason to wait. IBD can present more insidiously or bilaterally. Ocular disease can precede joint/bowel symptoms; the original up-to10 years needs its source and should not define a fixed screening interval. 1
TINU often presents with bilateral anterior inflammation and renal abnormalities; it is not confined to adolescent girls. Fever, arthralgia, weight loss, creatinine, urinalysis and urinary beta-2-microglobulin can guide renal assessment; the original mean age 20 years is not a universal diagnostic benchmark. Coordinate nephrology when appropriate. 1
Unilateral hypertensive keratouveitis, reduced corneal sensation and sectoral iris atrophy suggest HSV/VZV, but CMV may overlap. Posner–Schlossman describes marked pressure elevation with mild cells, sometimes 0.5+, over hours/days; CMV is an important cause but not every case is viral-confirmed. Choose aqueous PCR when it will clarify management; absence of atrophy or sensory change is not by itself a universal mandate or exclusion test. 1 4
Consider mechanical UGH from iris chafing by an IOL, even occasionally an in-the-bag lens, rather than assuming every pseudophakic inflammation is autoimmune. Capsule rupture, trauma, hypermature lens or retained lens material can cause lens-related inflammation. Review medicines, including bisphosphonates and historical metipranolol; an association requires clinical assessment rather than automatic withdrawal of essential treatment. 1
04Recognise chronic disease without rigid exclusions
JIA-associated chronic anterior uveitis is often bilateral, non-granulomatous and silent in children under 16, but presentations vary. ANA positivity, young onset (original below 7 years) and oligoarticular disease (original fewer than 5 joints) inform risk; female sex is not a standalone marker of severe outcome. Band keratopathy, synechiae, glaucoma, cataract, CME, phthisis and amblyopia make screening essential. The selected ACR guideline conditionally recommends 3-month screening for high-risk children, not a universal 3–4 month schedule for every child. 3
Fuchs is often chronic, unilateral and mild with stellate KPs, diffuse stromal atrophy, possible heterochromia, vitritis and fine nodules/angle vessels. The original near 100% stellate-KP claim is not universal. Synechiae or preoperative CME should prompt reconsideration rather than act as infallible exclusions. Rubella-associated Fuchs and Fuchs-like CMV are not simply identical diseases; selected viral testing may alter treatment. Often manage cataract/glaucoma instead of prescribing indefinite steroids. 4 5
A selected antibody-positive cohort included 100 patients/107 eyes:86 rubella-positive and 21CMV-positive eyes. Only 9/86 rubella-positive eyes met all applied SUN Fuchs criteria. Selection, antibody rather than uniform PCR confirmation and classification-versus-diagnosis differences limit extrapolation; it illustrates phenotypic variability, not the prevalence or sensitivity of every clinical Fuchs sign. 5
Sarcoidosis may be bilateral granulomatous disease with KPs, nodules and synechiae. ACE/lysozyme and chest imaging support selected assessment; tissue can establish systemic disease, while ocular diagnostic categories can remain probable. TB may mimic it, but a positive PPD/IGRA or response to anti-TB treatment does not alone prove ocular TB. Coordinate infection assessment before immunosuppression. 1
Syphilis can imitate many patterns and needs appropriate paired serology. Consider brucellosis with relevant unpasteurised-dairy exposure, chronic postoperative endophthalmitis including Cutibacterium acnes (formerly P.acnes), and persistent viral disease. Months-to-years postoperative inflammation is not automatically sterile. Idiopathic disease is a conclusion after appropriate reassessment, not an exemption from infection review. Nummular keratitis can accompany the original brucellosis differential but does not establish it alone. 1
05Treat inflammation and cause with a monitored plan
Topical corticosteroids such as prednisolone acetate can control anterior inflammation, sometimes initially hourly, followed by an activity-guided taper. Product, severity, infection and pressure response matter; no fixed taper suits every patient. Viral disease may require organism-specific antiviral treatment with specialist-directed anti-inflammatory care rather than steroid monotherapy. 1 6
Cycloplegia reduces ciliary pain and helps prevent/break synechiae. Tropicamide or cyclopentolate and longer-acting atropine have different roles; the original blanket claim that atropine promotes adhesions is not a verified general rule. Severe, recurrent, bilateral or systemic disease may need methotrexate or selected biologics with rheumatology; anti-TNF and anti-IL-6 are not interchangeable universal first choices. 1 3 6
Monitor glaucoma/pressure and distinguish inflammation from steroid response. Elective cataract surgery often aims for at least 3 months of quiescence with a tailored perioperative plan, while childhood visual development or urgent pathology can change timing. A JIA label alone does not make every drainage implant preferable to trabeculectomy. Uveitic CME needs control of its cause; NSAIDs, local/systemic steroids or selected off-label anti-VEGF are not equally supported or interchangeable options. 1 3 6
Coordinate eye and systemic treatment even when joints appear quiet. Visits assess activity, pressure, lens, macula and drug toxicity; recurrence prevention and visual development matter alongside treating the present flare. ACR JIA monitoring is at least every 3 months when controlled on stable treatment and earlier after changes, including within 1 month of topical steroid changes and 2 months of systemic changes; this population-specific guidance does not define every adult schedule. 3
| Disease | Typical course | Clues | Association | Management boundary |
|---|---|---|---|---|
| HLA-B27 | Acute recurrent unilateral/alternating | Fibrin/hypopyon may occur | Spondyloarthritis/IBD | Treat activity; systemic care if needed |
| JIA | Chronic often bilateral silent | White eye despite activity | Oligoarticular/ANA risk | Risk-based screening; selected MTX/biologic |
| Viral anterior uveitis | Often unilateral/keratouveitis | Pressure, sensation and iris pattern | HSV/VZV/CMV differ | Selected PCR and specific antiviral care |
| Fuchs | Chronic mild often unilateral | Stellate KPs, atrophy, vitritis | Rubella/Fuchs-like CMV distinction | Often treat cataract/glaucoma; reassess atypical CME/synechiae |
| Sarcoidosis | Often bilateral granulomatous | KPs, iris nodules, synechiae | Systemic sarcoidosis | Selected imaging/tissue and steroid-sparing care |
| TB | May mimic sarcoidosis | Granulomas/phlyctenules/test context | M.tuberculosis | Positive test or response alone is not proof |
| TINU | Often bilateral acute | Renal dysfunction/urinary beta-2-microglobulin | Not limited to young women | Coordinate renal and ocular care |
What are the main learning points?
Count and document activity, assess infection and systemic associations, then match anti-inflammatory and cause-directed treatment.
When is assessment urgent?
Rapid visual loss, severe pain, hypopyon, marked pressure rise, corneal ulcer or suspected infection/neurological disease needs urgent assessment; a quiet child’s eye still needs scheduled screening.
References and access status
- 1Immutable original export; anterior-uveitis lecture export; speaker/recording unverified
Complete export read; original attribution and any recording/transcript or appointment not independently verified.
- 2SUN first international workshop, 2005
Historical SUN tables/definitions access 10 November from review 080 plus selected indexed statements 15 November; not new complete main-report access.
- 3ACR/AF JIA-associated uveitis guideline,2019
Selected indexed Table 3 screening/monitoring recommendations read 15 November 2026; broader treatment scope from historical 080/081 ledgers. Not full guideline or high-certainty evidence for all paediatric uveitis.
- 4SUN CMV anterior uveitis criteria,2021
Selected indexed original introduction/phenotype discussion read 15 November 2026; full machine-learning methods and performance tables not appraised.
- 5Rubella/CMV cohort and Fuchs classification,2022
Complete indexed abstract and selected discussion read 15 November 2026; 100 patients 107 eyes, selected antibody-positive cohort; no complete methods/figures appraisal.
- 6Review 023/081: systemic therapy and infection source records
Historical limited source appraisal reused; current full local product information, primary protocols and specialist case review pending.
For patients
The front of the eye may be inflamed even when it looks white. Use only the prescribed drops and return for pressure and inflammation checks.
Examination and selected tests guide individual treatment and follow-up; this educational text cannot replace your own assessment.
Rapid visual loss, severe pain, hypopyon, marked pressure rise, corneal ulcer or suspected infection/neurological disease needs urgent assessment; a quiet child’s eye still needs scheduled screening.
Rapid visual loss, severe pain, hypopyon, marked pressure rise, corneal ulcer or suspected infection/neurological disease needs urgent assessment; a quiet child’s eye still needs scheduled screening.